A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-548
Clinical trial NCT05455502 · COMPLETED
Trial details
- NCT number
- NCT05455502
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2022-09-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.